Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective, unicenter, randomized controlled trial evaluates whether a positive bile culture at index ERCP with plastic stenting identifies patients who benefit from earlier stent exchange. Patients with no previous history of sphincterotomy and positive bile cultures after an ERCP will be randomized to stent exchange at 1 month versus 3 months to assess whether personalized scheduling reduces early stent occlusion and secondary acute cholangitis.
A positive bile culture obtained at the index ERCP in patients with no previous history of sphincterotomy undergoing plastic biliary stenting may represent a key, yet currently largely ignored, predictor of early stent occlusion and subsequent acute cholangitis. Based on the findings of the TEMPEST Study, conducted in the Gastroenterology Department of Colentina Clinical Hospital (currently submitted for publication), which suggested a clinical benefit of earlier scheduled ERCP for stent exchange in this high-risk subgroup, we hypothesize that bile culture-guided scheduling of stent exchange can improve clinical outcomes.
To test this hypothesis, we propose a prospective, unicentric, randomized controlled trial comparing patients with positive bile cultures at index ERCP randomized to early stent exchange at 1 month versus standard exchange at 3 months. The primary objective is to determine whether personalized scheduling based on initial bile culture results reduces the incidence of early acute cholangitis, thereby offering a simple, low-cost strategy to optimize post-ERCP management and prevent further complications.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Other | standard follow up and stent exchange according to institutional norm |
|
| rapid exchange | Active Comparator | rapid call back in case of positive bile culture |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| stent exchange | Other | standard stent exchange at three months according to the institutional norms |
|
| Measure | Description | Time Frame |
|---|---|---|
| Comparative analysis of the incidence rates of acute cholangitis in the scheduled stent exchange group, at one month, vs. standard stent exchange at three months | The primary endpoint of this study is the incidence of cholangitis in patients with a positive bile culture at index ERCP with plastic stent placement. By comparing the outcomes between the 2 groups, the study aims to demonstrate that earlier stent exchange in this high-risk subgroup improves patient outcome by decreasing procedure-related complications, supporting a personalized management strategy instead of the current standard. | from enrollment to the end of treatment at three months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bogdan R. Mateescu, Prof. M.D., Ph.D | Contact | 21 317 3245 | +40 | bogmateescu@gmail.com |
| Andrei M. Voiosu, M.D., PhD. | Contact | 21 317 3245 | +40 | andreivoiosu@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Colentina Clinical Hospital | Bucharest | Bucharest | 021025 | Romania |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with plastic biliary stent placement and a positive bile culture at index ERCP will be randomized into two groups: Group A, scheduled for early plastic stent exchange at 1 month, and Group B, scheduled for standard stent exchange at 3 months
Not provided
Not provided
Not provided
Not provided
| Scheduled biliary stent exchange at one month | Other | Patients within the active arm will have scheduled stent exchange at one month, in comparison to those in the control arm, which will have scheduled stent exchange at three months, according to the institutional norms in place |
|